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Summary
 
Early infection with murine cytomegalovirus (MCMV) induces circulating levels of interleukin
(IL)-12, interferon (IFN)-
 
g
 
, and tumor necrosis factor (TNF). Studies presented here further
characterize these responses by defining kinetics and extending evaluation to include IL-1, IL-6,
and glucocorticoids. IL-12 p40, IFN-
 
g
 
, TNF, IL-1
 
a
 
, and IL-6 were shown to be increased,
but IL-1
 
b
 
 was undetectable, in serum of MCMV-infected mice. The IL-12 p40, IFN-
 
g
 
, TNF,
and IL-6 responses were dramatic with peak levels reaching 
 
.
 
150–10,000 pg/ml at 32–40 h
after infection and rapidly declining thereafter. Glucocorticoid induction, peaking at 36 h and
reaching 30-fold increases above control values, accompanied the cytokine responses. Mice
with cytokine deficiencies or neutralized cytokine function demonstrated that IL-6 was the
pivotal mediator of the glucocorticoid response, with IL-1 contributing to IL-6 production.
The IL-6 requirement appeared to be specific for virus-type stimuli as the synthetic analogue of
viral nucleic acid, polyinosinic-polycytidylic acid, also induced IL-6–dependent glucocorticoid
release, but treatments with the bacterial product lipopolysaccharide and a non-immune physical
restraint stressor elicited IL-6–independent responses. Collectively, the results identify IL-6 as a
primary mediator of glucocorticoid induction, and elucidate specific pathways of interactions
between immune and neuroendocrine systems during viral infection.
 
T
 
he cytokines IL-12, IFN-
 
g
 
, TNF, IL-1, and IL-6 are in-
duced under conditions of sepsis with gram-negative
bacteria and in response to administration of the gram-neg-
ative bacterial product endotoxin, i.e., LPS (1, 2). High
levels of these cytokines contribute to pathologies charac-
terized as endotoxin-induced shock with wasting, thymic
atrophy, and life-threatening states (1–3). Circulating TNF,
IL-1, and/or IL-6, elicited as a cascade after exposure to
LPS (4–6) or after administration of purified cytokines (7),
induce the steroid hormones glucocorticoids. Induction is
largely a result of hypothalamic-pituitary-adrenal (HPA)
 
1
 
 axis
activation through stimulating hypothalamus production of
corticotropin-releasing hormone (CRH), which induces pi-
tuitary release of adrenocorticotropin hormone (ACTH) for
stimulation of adrenal gland glucocorticoid production.
Glucocorticoids can suppress multiple immune functions, in-
cluding cytokine production and T cell responses (4, 8, 9).
Thus, the immune and neuroendocrine systems can com-
municate to provide feedback inhibition mechanisms limit-
ing immune responses.
In addition to stimulation as a result of cytokine re-
sponses to bacterial LPS, glucocorticoid release through the
HPA axis occurs as part of circadian rhythm (10) and is in-
duced by a variety of other stimuli including physical or
cognitive stress (11), a synthetic analogue for viral nucleic
acids, i.e., polyinosinic-polycytidylic acid (poly I:C) (12),
and turpentine induction of inflammation (3, 13). The pre-
cise pathways for HPA axis activation under each of these
conditions has yet to be fully elucidated, and little is known
about endogenous induction in response to infections. If
glucocorticoids are elicited during challenge with patho-
gens, they may shape or modulate down-stream T cell
functions as well as control acute detrimental cytokine-
mediated pathologies (4, 8, 9).
This laboratory has been examining cytokine responses
and functions during viral infections (14–16). In particular,
responses to infections of mice with the cytopathic (14–18)
murine cytomegalovirus (MCMV) are being investigated.
 
1
 
Abbreviations used in this paper: 
 
ACTH, adrenocorticotropin hormone;
CRH, corticotropin-releasing hormone; HPA, hypothalamic-pituitary-
adrenal; MCMV, murine cytomegalovirus; NDV, Newcastle disease vi-
rus; poly I:C, polyinosinic-polycytidylic acid.
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Early Cytokine and Glucocorticoid Responses to Murine Cytomegalovirus
 
Our group has shown that systemic levels of IL-12, IFN-
 
g
 
,
and TNF are induced at early times after infection (15, 16).
The present studies were undertaken to more precisely de-
fine the early MCMV-elicited cytokine responses, to ex-
tend characterization to IL-1 and IL-6, and to determine the
effects of cytokine expression on endogenous glucocorti-
coid responses. Our results demonstrate that MCMV stim-
ulates dramatic and tightly regulated early IL-12, IFN-
 
g
 
,
TNF, IL-1, and IL-6 responses with an accompanying glu-
cocorticoid response. The key mediator of glucocorticoid
induction is shown to be IL-6 with IL-1 acting to stimulate
IL-6 production. These studies define an IL-6–dependent
pathway for endogenous glucocorticoid induction. More-
over, they suggest that distinct pathways are in place for
communication between immune and neuroendocrine sys-
tems during infections with different types of pathogens.
 
Materials and Methods
 
Mice.
 
5–15-wk-old, male, C57BL/6 (C57BL/6NTacfBR;
Taconic, Germantown, NY), IL-6–deficient (B6,129-IL6
 
,
 
tm1koe 
 
.
 
;
Jackson Laboratory, Bar Harbor, ME), wild-type control for IL-6–
deficient ([B6129F1/J-A
 
,
 
W-J
 
.
 
/A
 
,
 
w
 
. 
 
F 
 
3
 
 B6129F1/J-A 
 
,
 
w-J
 
.
 
/A
 
,
 
w
 
.
 
M]F2, Jackson Laboratory), and IFN-
 
g
 
–deficient C57BL/6
(a kind gift from Joan Stein-Streilein, Massachusetts General Hos-
pital, Boston, MA) mice were housed in the Brown University
Animal Care Facility for at least 1 wk before use, and kept on a
12 h light/dark cycle with lights on at 6:00 AM. Except for desig-
nated experimental manipulations, mice were minimally dis-
turbed. Protocols were in accordance with institutional guidelines
for animal care and use.
 
Virus and Viral Plaque Assays.
 
Stocks of salivary gland–extracted
MCMV, Smith strain, were generated as previously described
(15). Mice were intraperitoneally infected with MCMV in 100 
 
m
 
l
or control injected with 100 
 
m
 
l of vehicle alone (1
 
3
 
 media 199;
GIBCO BRL, Gaithersburg, MD) between 7:00 and 8:00 PM.
To determine optimal doses, ranges of virus between 1
 
 3 
 
10
 
5
 
 and
6.3
 
 3 
 
10
 
3
 
 PFU/mouse were tested. Cytokines were detectable 36 h
after infection with doses as low as 6.3
 
 3 
 
10
 
3
 
. As peak cytokine
production and 100% long-term survival was obtained with 1
 
 3
 
10
 
5
 
 or 5
 
 3 
 
10
 
4
 
 PFU/mouse, these MCMV doses were used. He-
patic viral titers were assessed with plaque assays on NIH-3T3 fi-
broblasts (gift of Ann Campbell, Eastern Virginia Medical School,
Norfolk, VA). To enumerate plaques, cells were fixed with 10%
buffered formalin (Fisher Scientific, Pittsburgh, PA) and stained
with 0.1% crystal violet. Titers were quantitated as PFU/gram of
tissue.
 
In Vivo Treatments.
 
Rat anti–mouse IFN-
 
g
 
 mAb (XMG1.2)
and control IgG (Sigma Chem. Co., St. Louis, MO), 1 mg/mouse,
were injected intraperitoneally 12 h before infection. Anti–IFN-
 
g
 
antibody treatments eliminated detectable serum IFN-
 
g
 
, i.e.,
 
.
 
99% effectiveness, as tested by ELISA. Human IL-1 receptor
antagonist (IL-1ra) (gift from Synergen, Boulder, CO) was ad-
ministered by continuous infusion from subcutaneous pumps
(ALZET, Palo Alto, CA) with a delivery rate of 125 
 
m
 
g/h or 3
mg/d for 7 d. Control mice received pumps delivering PBS.
Pumps were implanted 3 d before injections. Serum IL-1ra levels
in IL-1ra–treated mice were between 12 and 36 
 
m
 
g/ml, as deter-
mined using commercial ELISA kits (R&D Systems, Inc., Min-
neapolis, MN). Levels were sufficient to block 
 
.
 
95% of IL-1 ac-
tivity (19), i.e., 
 
.
 
1,000 times in excess of maximum serum IL-1
 
a
 
detected in normal infected mice (see Results). Control mice had
IL-1ra levels at or below limit of detection (47 pg/ml).
LPS from 
 
Salmonella enteritidis
 
 (Sigma Chemicals) and poly I:C
(Sigma) were administered intraperitoneally at 50 
 
m
 
g/mouse and
100 
 
m
 
g/mouse, respectively, in 100 
 
m
 
l volume of PBS. Based on
other studies of peak cytokine responses (12, 13; Cousens L.P.,
and C.A. Biron, manuscript in preparation), serum was collected
2 h after injection. Restraint was used as a non-immune stressor
and administered by placing mice into a vented conical tube for
30 min before serum collection (20).
 
Serum and Organ Collection.
 
For serum corticosterone and ACTH
measurements, blood was collected from mice under low stress
conditions, i.e., within 2 or 4 min of handling. Mice were retro-
orbitally bled under methoxyflurane anesthesia (Metofane, Pit-
man-Moore, Mundelein, IL) into heparinized tubes. As there was
always some clotting of samples, the fluid was identified as serum.
Samples were centrifuged to pellet cells, collected and stored at
 
2
 
80
 
8
 
C. Lateral lobes of livers were harvested, placed into media
and stored at 
 
2
 
80
 
8
 
C for use in viral plaque assays.
 
Cytokine and Corticosterone Measurements.
 
Serum cytokine lev-
els were determined by standard sandwich ELISA. Assays for IL-6
used different purified capture and biotinylated detection anti–IL-6
monoclonal antibodies (PharMingen, San Diego, CA). IL-1
 
a
 
 and
IL-1
 
b
 
 levels were measured using ELISA kits (IL-1
 
a
 
; Genzyme,
Cambridge, MA; IL-1
 
b
 
; R&D Systems). Assays were performed
according to manufacturer protocols, and limits of detection were
160, 60, and 15 pg/ml, respectively. Assays for TNF, IFN-
 
g
 
, and
IL-12 p40 were performed as previously described (15, 16). The
TNF assay was specific for TNF-
 
a
 
. Colorimetric changes of en-
zyme substrates were detected using a Dynatech MR 4000 reader
(Chantilly, VA). Limits of detection for IL-12, IFN-
 
g
 
, and TNF
were 40 pg/ml. Commercially available assay kits were used for
determinations of plasma corticosterone (Immunochem
 
Ô
 
, ICN
Biomedicals, Costa Mesa, CA) and ACTH (Allegro HS-ACTH,
Nichols Institute, San Juan Capistrano, CA). Limits of detection
were 5 ng/ml and 5 pg/ml, respectively.
 
Statistical Analysis.
 
Where indicated, 
 
p
 
-values were obtained by
comparing groups using a student’s 
 
t
 
 test. For experiments exam-
ining corticosterone responses to LPS and poly I:C in IL-6–deficient
mice, a two-way ANOVA was used to evaluate group (deficient
versus normal) as well as treatment effects (LPS versus poly I:C).
The Student-Newman-Keuls test was used to assess for differ-
ences between specific pairs of group means.
 
Results
 
Kinetics of Cytokine Responses to MCMV Infection.
 
This lab-
oratory’s previous studies, of daily sampling, have shown
induction of detectable IL-12, IFN-
 
g
 
,
 
 
 
and TNF produc-
tion on day 2 of MCMV infection (15, 16). Experiments
were undertaken with more frequent serum sampling to
further characterize kinetics and peak responses of these cy-
tokines, and to extend evaluation to IL-1
 
a
 
, IL-1
 
b
 
, and IL-6.
Consistent with the earlier work, it was not possible to de-
tect IL-12 p40, IFN-
 
g
 
, or TNF in serum samples, from 4
C57BL/6 mice per group, receiving control vehicle injec-
tions or taken at 12-h intervals at, or before, 24 and after 72 h
of MCMV infection. However, the three cytokines were
observed at both 36 and 48 h after infection. At 36 h after
infection with 1
 
 3 
 
10
 
5
 
 PFU/mouse, serum values reached
the following pg/ml (
 
6
 
 SE): IL-12, 1431 
 
6 
 
54.4; IFN-
 
g
 
,
8733 
 
6
 
 481.1; and TNF, 436 
 
6
 
 9.5. By 48 h of infection, 
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peak levels had decreased by 
 
.
 
70% for IL-12 or IFN-
 
g
 
 and
by 50% for TNF. Because cytokine values had sharp rises and
falls within 12 h intervals, levels were determined in sam-
ples taken at 2 to 4 h intervals during the first 24–48 h of
MCMV infection (Fig. 1). Based on preliminary experi-
ments with a variety of doses (see Materials and Methods),
infections were initiated with 5
 
 3 
 
10
 
4
 
 PFU of virus.
 
 
 
Serum
IL-12, IFN-
 
g
 
, and TNF levels were found to crest be-
tween 36 and 40 h of infection with peak values of IL-12
p40 at 
 
z
 
500 pg/ml (Fig. 1 
 
A
 
), IFN-
 
g
 
 in excess of 10,000
pg/ml (Fig. 1 
 
B
 
), and TNF in excess of 150 pg/ml (Fig. 1 
 
C
 
).
The kinetics of serum IL-12 and IFN-
 
g
 
 responses were
rapid and sharp with peak IL-12 occurring slightly before
peak IFN-
 
g
 
 and both responses dramatically subsiding within
the next 4–10 h (Fig. 1, 
 
A
 
 and 
 
B
 
). Peak TNF levels were
achieved at 
 
,
 
4 h preceding peak IL-12 and maintained for
longer periods of time (Fig. 1 
 
C
 
). Measurements of IL-6
showed that this cytokine had kinetics reflecting IL-12 and
IFN-g; IL-6 reached peak levels of .5,000 pg/ml at 38 h
and subsided by 48 h after infection (Fig. 1 D). These re-
sults demonstrate that MCMV induces significant and
tightly regulated levels of serum IL-12, IFN-g, TNF, and
IL-6.
Both isoforms of IL-1, i.e., IL-1a and IL-1b, were mea-
sured. It was not possible to detect IL-1b in any serum
samples from four different experiments, with 2 to 6 C57BL/6
mice per group, and sampling at the following times after
MCMV infection: (a) days 0, 2, 5 or 7, (b) 12-h intervals
from 36 to 60 h, or (c) 4-h intervals from 12 to 36 h (data
not shown). In contrast, IL-1a was detected in all serum
samples tested, including those from uninfected mice re-
ceiving control vehicle injections (Fig. 1 E). Although there
was more variability and a wider range of values than those
observed for the other cytokines, IL-1a levels were ele-
vated at 18–36 h after MCMV infection (Fig. 1 E). To com-
pare MCMV induction of IL-1a and IL-1b to other known
inducers of IL-1, serum samples were obtained from mice
treated with bacterial LPS or with the synthetic double
stranded analogue for viral nucleic acid poly I:C. IL-1a was
detectable in either LPS (122.7 6 10 pg/ml) or poly I:C-
treated (66.6 6 14 pg/ml) mice, with LPS inducing rela-
tively high (173.5 6 21 pg/ml), but poly I:C inducing low
(25.9 6 14 pg/ml), levels of serum IL-1b (all values are
means 6 SD of 2 mice per group). Thus, in contrast to the
clear induction of IL-1b by LPS, MCMV appears to have a
unique selective induction, and poly I:C a preferential in-
duction, of IL-1a as compared to IL-1b.
Glucocorticoid and ACTH Responses during MCMV Infec-
tion. Because certain of these cytokines can induce gluco-
corticoid production as a result of activation of the HPA
axis, and because ACTH is the upstream HPA axis compo-
nent mediating stimulation of glucocorticoids, serum levels
of corticosterone, the natural murine glucocorticoid, and
ACTH were examined. Under low stress conditions, AM
values for corticosterone (6 SE) in uninfected mice aver-
aged 5.5 6 1.3 ng/ml. The diurnal rise resulted in average
peak PM values of 120 6 14 ng/ml. Serum corticosterone
levels, initially measured at 12 h intervals (Fig. 2 A), were
induced at 24, 36, and 48 h after MCMV infection. Maxi-
mal increases, compared to uninfected controls, were ob-
served at the AM time point 36 h after infection, i.e., 150
ng/ml, a 30-fold increase (Fig. 2 A). The PM values were
Figure 1. Serum cytokine levels between 24 and 48 h after MCMV infection. IL-12 p40 (A), IFN-g (B), TNF (C), IL-6 (D), and IL-1a (E) were as-
sessed in sera collected from MCMV-infected (5 3 104 PFU/mouse) and vehicle-treated C57BL/6 mice at various times between 24 and 48 h of infec-
tion by ELISA assays as described in Materials and Methods. IL-12 p40, IFN-g, TNF, and IL-6 values are from two mice at each time point and are ex-
pressed as means 6 SD. IL-1a values are plotted from individual mice at the indicated times after infection with geometric means indicated by short lines.
The IL-1a samples were taken from two different experiments. Uninfected samples for all cytokines were from mice receiving control vehicle injections.1188 Early Cytokine and Glucocorticoid Responses to Murine Cytomegalovirus
increased to 250 ng/ml, however, as control corticosterone
levels had diurnal increases, net inductions at these times
were only twofold. Examination of additional time points
(Fig. 2 B) demonstrated that peak corticosterone responses
were at 36 h. This MCMV induction of glucocorticoids at
36 h has been observed in .10 independent experiments
with groups of 2–6 mice. In other experiments, ACTH
levels were shown to be significantly increased at 28 and 32 h
after MCMV infection (Fig. 2 C). Thus, dramatic endoge-
nous glucocorticoid and ACTH responses accompany cir-
culating cytokine induction during MCMV infections.
Role of Cytokines in MCMV-Induced Glucocorticoid Re-
sponses. To characterize the contribution of early cytokine
production to induction of glucocorticoid responses, serum
corticosterone levels were examined in mice with specifi-
cally neutralized endogenous cytokine functions. Individual
cytokine functions were evaluated in mice with targeted
disruptions of the IL-6 or IFN-g genes and in normal mice
treated with neutralizing anti–IFN-g antibodies or IL-1 re-
ceptor antagonist (IL-1ra). MCMV-induced corticosterone
levels were not modified significantly by the presence or
absence of IFN-g; infected IFN-g–deficient (Fig. 3) and
anti–IFN-g–treated (data not shown) mice had serum cor-
ticosterone values similar to those in respective infected
control mice. In contrast, MCMV-infected IL-6–deficient
and IL-1ra–treated mice demonstrated dramatically reduced
corticosterone levels in comparison to respective infected
control mice; serum corticosterone levels were decreased by
up to 75% in IL-6–deficient mice and by .50% in IL-1ra–
treated mice (Fig. 3). Reductions resulting from IL-6 defi-
ciencies were observed in three independent experiments
with each experiment containing three mice/group, and
those resulting from blocking IL-1 function were observed
in two independent experiments with each containing
three mice/group. Statistical significance was increased by
combination of results from multiple experiments such that
the IL-1ra effects were to P ,0.05 and the IL-6 deficiency
effects were to P ,0.01. The cytokine effects on glucocor-
ticoid induction were not a consequence of changes in re-
sponse kinetics as, in addition to the shown dramatically
reduced glucocorticoid levels at 36 h, MCMV-infected
IL-6–deficient mice also lacked induced glucocorticoid lev-
els at 24, 48, and 60 h after infection (data not shown). Thus,
blocks in endogenous IL-6 or IL-1 functions dramatically
Figure 2. Serum corticosterone and ACTH levels after MCMV infec-
tion. Corticosterone and ACTH levels were measured in serum samples
collected from C57BL/6 mice under low stress conditions (mice were bled
within 4 min of handling for corticosterone measurement and within 2
min of handling for ACTH measurement). Serum corticosterone was mea-
sured at 12-h intervals between 12 and 72 h (A) or 2–4-h intervals be-
tween 24 and 48 h (B) and serum ACTH was measured at 4–6-h intervals
between 18 and 36 h after MCMV (5 3 104 PFU/mouse) infection (open
circles) or vehicle injection (open squares). In A, data are mean 6 SE of four
mice per time point. In B, data are means 6 SD of two mice per time
point. For C, data are means 6 SE of three mice per time point. *P
,0.05, **P ,0.01.
Figure 3. Corticosterone levels in mice with neutralized cytokine
function. Corticosterone levels in MCMV-infected (5 3 104 PFU/
mouse) (filled bar) or vehicle-injected (striped bar) IL-6–deficient (IL-6–),
IFN-g–deficient (IFN-g2), IL-1ra–treated (IL-1ra) mice or respective
control mice (IL-61, IFN-g1, PBS). Treatments were as described in Ma-
terials and Methods. Corticosterone levels were measured in serum sam-
ples collected from mice under low stress conditions (bled within 4 min
of handling) 36 h after infection. Results from one of two to three exper-
iments are shown. Data are means 6 SE of three mice per group. **P
,0.01.1189 Ruzek et al.
attenuate glucocorticoid responses to MCMV infection.
Studies were carried out to determine whether modula-
tion of pathogen burdens or other endogenous cytokines
may have contributed to reduced corticosterone levels. At
the 36 h infection time point, log viral titers ranged be-
tween 4.3 and 5.1 PFU/g of liver. Effects on glucocorti-
coids were independent of modified viral burden as, at this
time, there were no significant differences in any experi-
mental or treatment groups, compared to respective con-
trols, including IL-6–deficient and IL-1ra–treated (data not
shown). They were also independent of IFN-g changes; this
cytokine was not detectable in mice with a mutated IFN-g
gene or those treated with antibody neutralizing IFN-g and
was not dramatically inhibited in mice having had other
cytokines blocked (data not shown). TNF levels also did
not appear to be significantly altered in any of the cyto-
kine-deficient or -blocked mice. Compared to wild-type
controls, IL-1a levels were reduced in IFN-g–deficient
mice [113 6 37 versus 41 6 5 pg/ml (mean 6 SE of 3
mice)], but increased in IL-6–deficient mice [92 6 32 versus
211 6 53 pg/ml (mean 6 SE of 3 mice)]. In contrast to the
increased IL-1a in IL-6–deficient mice, IL-6 levels were
dramatically reduced in IL-1ra–treated mice by up to 70%.
Serum IL-6 values in IL-1ra–treated mice were 369 6 126
pg/ml as compared to PBS-treated levels of 1,500 6 467
pg/ml (values are mean 6 SE of three mice per group).
Upon combination of results from multiple experiments,
IL-1ra effects on IL-6 were statistically significant to P
,0.05. Thus, although cytokine neutralization or deficiency
did not affect viral load or production of most cytokines
during MCMV infection, IL-1ra treatment decreased se-
rum IL-6 levels. Taken together with the demonstrated IL-1a
expression in the absence of IL-6, these data indicate that
IL-6 is a critical and required cytokine for induction of peak
glucocorticoids during MCMV infection, and that IL-1a is
playing a secondary role by contributing to IL-6 induction.
Glucocorticoid Responses to Non-Viral Stimuli in IL-6–defi-
cient Mice. To characterize the role of endogenous IL-6 for
glucocorticoid induction by other non-viral and replica-
tion-independent stimulators of the HPA axis, responses to
LPS, poly I:C, and restraint stress were evaluated in IL-6–
deficient mice. Modest, but statistically significant, reduc-
tions of corticosterone levels were observed in response to
LPS treatment of IL-6–deficient as compared to similarly
treated wild-type mice (Fig. 4 A). In contrast, IL-6–defi-
cient mice treated with poly I:C demonstrated significantly
and profoundly decreased, i.e., up to 85%, glucocorticoid re-
sponses compared to wild-type poly I:C–treated mice (Fig. 4
A). Two way ANOVA also revealed significant main effects
of both group (IL-6–deficient versus wild-type control)
(F[1,23] = 78.2, P ,0.0001) and treatment condition (PBS
versus poly I:C versus  LPS) (F[2,23] 5 84.5, P ,0.0001)
on corticosterone concentrations. This analysis demonstrated
that the poly I:C–treated group of IL-6–deficient mice was
significantly different from both the poly I:C–treated wild-
type group and the LPS-treated IL-6–deficient group. In
contrast, corticosterone levels were not significantly differ-
ent between PBS-treated IL-6–deficient and poly I:C–treated
IL-6–deficient mice. Activation of the HPA axis by the
non-immune physical restraint stressor was unaffected in
IL-6–deficient mice compared to wild-type controls (Fig. 4
B). These results demonstrate that glucocorticoid responses
to LPS or restraint stress are largely IL-6 independent, but,
as with MCMV infection, poly I:C–induced responses are
IL-6–dependent.
Discussion
The present studies demonstrate that, in addition to IL-12,
TNF, and IFN-g, MCMV infections of mice induce de-
tectable IL-1a and IL-6, but not IL-1b, production. The
IL-12, TNF, IFN-g, and IL-1a cytokines all rapidly reach
high peak levels in the circulation and decline shortly there-
after. Moreover, cytokine activation of the HPA axis ap-
pears to be engaged as endogenous serum corticosterone
and ACTH responses also are induced. IL-6 is the critical
and required factor leading to peak induction of endoge-
nous glucocorticoids, and IL-1a is a necessary factor for
optimal IL-6 production. This pathway to glucocorticoid
release through IL-1a and IL-6 is clearly delineated be-
cause IL-1b is undetectable in MCMV-infected mice and
because IL-1a levels are similar or greater in MCMV-
infected IL-6–deficient mice as compared to infected wild-
type controls. The IL-6 requirement for glucocorticoid re-
sponses is specific to viral infections and virus-type stimuli
because, although the synthetic double stranded analogue
for viral nucleic acid, poly I:C, the bacterial product, LPS,
and restraint stress all induce glucocorticoid responses in
normal mice, only peak responses to MCMV and poly I:C
are exquisitely dependent upon endogenous IL-6. Taken to-
gether, these results identify: (a) the kinetics and magni-
tudes of early circulating cytokine induction during MCMV
infection, (b) a unique IL-6–dependent glucocorticoid re-
sponse to viral infection and virus-type, non-replicating
Figure 4. Serum corticosterone levels after LPS, poly I:C, or restraint
stress administration in IL-6–deficient and wild-type mice. (A) Corticos-
terone levels were measured in plasma collected from IL-6–deficient
(IL-62) (filled bar) and wild-type (IL-61) (dotted bar) mice under low stress
conditions (less than 4 min of handling) 2 h after injection with PBS, 50 mg
LPS, or 100 mg poly I:C. (B) Corticosterone levels were measured in serum
samples collected from IL-6–deficient (IL-62) and wild-type (IL-61) mice
bled under low stress conditions (within 4 min of handling) or after 30
min of restraint. Data are means 6 SE of four mice per group. **P ,0.01.1190 Early Cytokine and Glucocorticoid Responses to Murine Cytomegalovirus
stimuli, and (c) a specific IL-1a to IL-6 induction pathway.
Furthermore, as they present evidence for a distinct cyto-
kine dependency for HPA axis activation, the studies begin
to define precise communication pathways between im-
mune and neuroendocrine systems under conditions of dif-
ferent microbial challenges.
IL-12, IFN-g, and TNF are important for antiviral de-
fense (15, 16) and, as IL-1 and IL-6 have known proin-
flammatory functions (19, 21), these factors may also pro-
mote defense against MCMV. However, at high systemic
levels, the cytokines can cause significant and life-threaten-
ing pathologies (1, 2, Orange, J.S., T.P Salazar-Mather,
and C.A. Biron, manuscript in preparation). As glucocorti-
coids can decrease production of multiple cytokines, includ-
ing IL-6, IFN-g, IL-1, and TNF (8), induction of these en-
dogenous steroid hormones by high virus-induced IL-6
levels may provide feedback inhibition to limit cytokine
responses and protect the host from cytokine-mediated dis-
ease (22). In support of this hypothesis, another acute viral
infection, lymphocytic choriomeningitis virus (LCMV), does
not induce detectable systemic cytokines (15; Ruzek, M.C.,
A.H. Miller, B.D. Pearce, and C.A. Biron, unpublished
observation) or significant levels of glucocorticoids (12,
Ruzek, M.C., A.H. Miller, B.D. Pearce, and C.A. Biron,
data not shown) at early times. As a consequence, immune
responses to MCMV are shaped and/or limited by factors in
addition to those influencing responses to LCMV. It is note-
worthy that in comparison to LCMV, MCMV infections
induce relatively weak later T cell responses (14). Thus,
glucocorticoids may be specifically elicited during certain
viral infections initiating a sequence of events with the po-
tential to result in cytokine-mediated detrimental effects,
i.e., inducing extremely high levels of cytokines, but not
during viral infections failing to do so, and these hormones
may shape additional down-stream immune responses to
these viruses.
The IL-1a–induced IL-6 requirement for optimal glu-
cocorticoid stimulation (Fig. 3) is consistent with studies
examining recombinant or purified factors in vivo. Admin-
istrations of TNF, IL-1, and IL-6 increase circulating ACTH
and corticosterone levels (5, 7) with IL-1b being the most
potent and rapid inducer (7). However, IL-1a, IL-1b, and
TNFa can all stimulate IL-6 production, with IL-1a being
a more potent inducer than either IL-1b or TNF (5, 23).
In addition, IL-1a and IL-6 have been shown to synergize
for release of ACTH (23, 24). This ability of IL-1a to in-
duce and synergize with IL-6 can explain the observation
that corticosterone responses after IL-6 administration alone
are not as great as those after IL-1 administration (23). As a
downstream or cooperative role of IL-6 has not been pre-
viously distinguished from direct stimulation, the reported
IL-1 requirement for corticosterone responses to pro-inflamm-
atory stimuli may be due to this factor’s ability to induce and
synergize with IL-6 (23, 24). In addition, given the differ-
ent potencies of IL-1a and IL-1b for IL-6 induction (5),
yet similar activity on the HPA axis (24), IL-1b alone may
induce glucocorticoids, but optimal glucocorticoid responses
to IL-1a may require IL-6. It is likely that serum IL-1a
values reported here are actually an underestimate of over-
all induced levels, as IL-1a is generally expressed in a
membrane-bound form (19).
Although the glucocorticoid response dependency on
IL-1a-induced IL-6 is consistent with results from admin-
istering cytokines, the IL-6 requirement in response to
challenge with particular agents appears to be specific to vi-
ral infections. Two additional systems have not found IL-6
essential for glucocorticoid induction; these are turpentine
and LPS challenges (13). IL-1b is readily detectable after in-
jection of LPS (6), however, it is undetectable in serum
from MCMV-infected mice. Therefore, during viral infec-
tion, the cytokines leading to glucocorticoid production may
be more dependent upon an IL-1a to IL-6 cascade, whereas
LPS and/or turpentine may induce other cytokines, includ-
ing IL-1b, that either alone or in combination induce glu-
cocorticoids independently of IL-6 (3). The poly I:C–induced
responses also appear to occur under conditions of minimal
IL-1b expression. Thus, the ability to define the IL-1a to
IL-6 pathway for glucocorticoid induction, in response to
MCMV and/or poly I:C, is most likely possible because of
the absence of parallel or overlapping pathways for induction.
A model for pathways of glucocorticoid induction, after viral
as compared to bacterial stimulation, is presented in Fig. 5.
Our results can be contrasted to others examining virus
activation of the HPA axis after exposure to Newcastle dis-
ease virus (NDV), influenza virus, and herpes simples type 1
(HSV-1) (25-27). NDV stimulates IL-1–dependent ACTH
and corticosterone release (25). However, NDV does not
productively infect mice and, similar to poly I:C responses,
increases in serum corticosterone are observed within hours
of injection (12, 25). Therefore, NDV does not reflect ac-
tual events occurring during infection of a permissive host.
Influenza virus infections and ocular infections of herpes
simplex virus type 1 (HSV-1) also induce increased corti-
costerone levels, but, in comparison to MCMV infection,
these responses peak much later (7 d after infection) and are
prolonged (26, 27). As both HSV-1 and influenza virus in-
fections can cause considerable additional physical distress
which may itself stimulate the HPA axis, it is likely that
other pathways are contributing to induction of glucocorti-
coid responses at later times after these infections. Interest-
ingly, several other viruses have been shown to stimulate
IL-6 mRNA expression in vitro (28). Although a thorough
comparison of IL-6 production and corticosterone re-
sponses has not been performed during each of these infec-
Figure 5. Model for microbial stimulation of glucocorticoid induction.1191 Ruzek et al.
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